Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pig

Pediatric Research

Volumn 64, Issue 3, 2008, Pages 251-255

  Belik, Jaques ^a,c   Tessler, Rogerio ^b   Wu, Shengping ^a   Fiori, Renato ^d   MacGowan, Christopher K ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; SODIUM CHLORIDE; VASODILATOR AGENT; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; ATELECTASIS; BRONCHUS OBSTRUCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPOXIC LUNG VASOCONSTRICTION; LOW DRUG DOSE; LUNG BLOOD FLOW; LUNG DISEASE; LUNG FLOW VOLUME CURVE; LUNG LOBE; LUNG PARENCHYMA; LUNG VENTILATION; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXYGEN TENSION; PRIORITY JOURNAL; SWINE; ANIMAL; ANOXIA; BLOOD FLOW; DISEASE MODEL; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LUNG CIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; ATELECTASIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; LUNG; MAGNETIC RESONANCE IMAGING; PIPERAZINES; PULMONARY CIRCULATION; PULMONARY VENTILATION; PURINES; REGIONAL BLOOD FLOW; SULFONES; SWINE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 55749103223     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31817d9b93     Document Type: Article

References (44)

1. Cook LN, Stewart DL 2005 Inhaled nitric oxide in the treatment of persistent pulmonary hypertension/hypoxic respiratory failure in neonates: an update. J Ky Med Assoc 103:138-147
2. Abman SH 2007 Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology 91:283-290
3. Juliana AE, Abbad FC 2005 Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164:626-629
4. Hemnes AR, Champion HC 2006 Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension. Expert Rev Cardiovasc Ther 4:293-300
5. Baquero H, Soliz A, Neira F, Venegas ME, Sola A 2006 Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117:1077-1083
6. Martell M, Blasina F, Silvera F, Tellechea S, Godoy C, Vaamonde L, Benenatti L, Olivera W 2007 Intratracheal sildenafil in the newborn with pulmonary hypertension. Pediatrics 119:215-216
7. Obaid L, Johnson ST, Bigam DL, Cheung PY 2006 Intratracheal administration of sildenafil and surfactant alleviates the pulmonary hypertension in newborn piglets. Resuscitation 69:287-294
8. Simiyu DE, Okello C, Nyakundi EG, Tawakal AH 2006 Sildenafil in management of persistent pulmonary hypertension of the newborn: report of two cases. East Afr Med J 83:337-340
9. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile LA, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA 2000 Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14-20
10. Ryhammer PK, Shekerdemian LS, Penny DJ, Ravn HB 2006 Effect of intravenous sildenafil on pulmonary hemodynamics and gas exchange in the presence and absence of acute lung injury in piglets. Pediatr Res 59:762-766
11. Shekerdemian LS, Ravn HB, Penny DJ 2004 Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 55:413-418
12. Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165:1098-1102
13. de Clety SC, Decell MK, Tod ML, Sirois P, Gordon JB 1998 Developmental changes in synthesis of and responsiveness to prostaglandins I2 and E2 in hypoxic lamb lungs. Can J Physiol Pharmacol 76:764-771
14. Gordon JB, Tod ML, Wetzel RC, McGeady ML, Adkinson NF Jr, Sylvester JT 1988 Age-dependent effects of indomethacin on hypoxic vasoconstriction in neonatal lamb lungs. Pediatr Res 23:580-584
15. Fike CD, Hansen TN 1987 Hypoxic vasoconstriction increases with postnatal age in lungs from newborn rabbits. Circ Res 60:297-303
16. Belik J, Sienko A, Light RB 1990 The effect of repeated intermittent hypoxia on pulmonary vasoconstriction in the newborn. Can J Physiol Pharmacol 68:355-362
17. Ryhammer P, Pedersen M, Ringgaard S, Ravn H 2007 Regional pulmonary perfusion using model-free analysis of contrast-enhanced MRI in meconium-aspirated piglets. J Magn Reson Imaging 26:296-303
18. Lotz J, Meier C, Leppert A, Galanski M 2002 Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics 22:651-671
19. Lankhaar JW, Hofman MB, Marcus JT, Zwanenburg JJ, Faes TJ, Vonk-Noordegraaf A 2005 Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging 22:73-79
20. Walker PG, Cranney GB, Scheidegger MB, Waseleski G, Pohost GM, Yoganathan AP 1993 Semiautomated method for noise reduction and background phase error correction in MR phase velocity data. J Magn Reson Imaging 3:521-530
21. Liljestrand G 1958 Chemical control of the distribution of the pulmonary blood flow. Acta Physiol Scand 44:216-240
22. Gordon JB, Hortop J, Hakim TS 1989 Developmental effects of hypoxia and indomethacin on distribution of vascular resistances in lamb lungs. Pediatr Res 26:325-329
23. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR 2001 Sildenafil inhibits hypoxiainduced pulmonary hypertension. Circulation 104:424-428
24. Fesler P, Pagnamenta A, Rondelet B, Kerbaul F, Naeije R 2006 Effects of sildenafil on hypoxic pulmonary vascular function in dogs. J Appl Physiol 101:1085-1090
25. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F 2002 Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895-900
26. Abrams D, Schulze-Neick I, Magee AG 2000 Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4
27. Nagdyman N, Fleck T, Bitterling B, Ewert P, Abdul-Khaliq H, Stiller B, Hubler M, Lange PE, Berger F, Schulze-Neick I 2006 Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr Res 59:462-465
28. Nieminen T, Koobi T, Tammela TL, Kahonen M 2006 Hypotensive potential of sildenafil and tamsulosin during orthostasis. Clin Drug Investig 26:667-671
29. Jackson G, Montorsi P, Cheitlin MD 2006 Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology 68:47-60
30. Shah PS, Ohlsson A 2007 Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev CD005494
31. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hubler M, Butrous G, Petros A, Lange P, Redington AN 2003 Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108:II167-II173
32. Schulze-Neick I, Redington AN 2004 Sildenafil, nitric oxide, and acute lung injury: pathophysiology beats pharmacotherapy? Pediatr Res 55:370-371
33. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS 2003 Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 29:1996-2003
34. Moudgil R, Michelakis ED, Archer SL 2005 Hypoxic pulmonary vasoconstriction. J Appl Physiol 98:390-403
35. Weissmann N, Nollen M, Gerigk B, Ardeschir GH, Schermuly RT, Gunther A, Quanz K, Fink L, Hanze J, Rose F, Seeger W, Grimminger F 2003 Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol 284:H931-H938
36. Archer SL, Tolins JP, Raij L, Weir EK 1989 Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun 164:1198-1205
37. MacLean MR, Johnston ED, McCulloch KM, Pooley L, Houslay MD, Sweeney G 1997 Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283:619-624
38. Kirsch M, Kemp-Harper B, Weissmann N, Grimminger F, Schmidt HH 2008 Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory upregulation of NO-cGMP signaling. FASEB J 22:30-40
39. Grimminger F, Spriestersbach R, Weissmann N, Walmrath D, Seeger W 1995 Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J Appl Physiol 78:1509-1515
40. Ide H, Nakano H, Ogasa T, Osanai S, Kikuchi K, Iwamoto J 1999 Regulation of pulmonary circulation by alveolar oxygen tension via airway nitric oxide. J Appl Physiol 87:1629-1636
41. Weissmann N, Winterhalder S, Nollen M, Voswinckel R, Quanz K, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F 2001 NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs. Am J Physiol Lung Cell Mol Physiol 280:L638-L645
42. Klass DJ 1978 Lung tissue guanosine 3′,5′-monophosphate: effects of ventilation and anesthesia. J Appl Physiol 45:487-494
43. Mathers J, Benumof JL, Wahrenbrock EA 1977 General anesthetics and regional hypoxic pulmonary vasoconstriction. Anesthesiology 46:111-114
44. Wetzel RC, Martin LD 1989 Pentobarbital attenuates pulmonary vasoconstriction in isolated sheep lungs. Am J Physiol 257:H898-H903